A newly launched St. Louis startup focused on providing research and development services for biotechnology and pharmaceutical companies has raised funding to expand its technology and headcount.
The startup, Panome Bio, said Wednesday it has closed a growth financing round led by San Francisco-based venture capital firm Telegraph Hill Partners. BioGenerator Ventures, the startup investment arm of St. Louis-based innovation hub BioSTL, also invested in the round. BioGenerator has assisted in creating Panome and provided capital to begin its operations, the startup said.